The role of molecular genetics in the clinical management of sporadic medullary thyroid carcinoma: A systematic review
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of molecular genetics in the clinical management of sporadic medullary thyroid carcinoma: A systematic review
Authors
Keywords
-
Journal
CLINICAL ENDOCRINOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-07-14
DOI
10.1111/cen.14060
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Selective RET kinase inhibition for patients with RET-altered cancers
- (2018) V Subbiah et al. ANNALS OF ONCOLOGY
- Circulating miR-375 as a novel prognostic marker for metastatic medullary thyroid cancer patients
- (2018) Paola Romeo et al. ENDOCRINE-RELATED CANCER
- Clinical significance of RET and RAS mutations in sporadic medullary thyroid carcinoma: a meta-analysis
- (2018) Huy Gia Vuong et al. ENDOCRINE-RELATED CANCER
- Global DNA methylation profile in medullary thyroid cancer patients
- (2018) Lucieli Ceolin et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Evaluation of miRNAs expression in medullary thyroid carcinoma tissue samples: miR-34a and miR-144 as promising overexpressed markers in MTC
- (2018) Noushin Shabani et al. HUMAN PATHOLOGY
- Large sporadic thyroid medullary carcinomas: predictive factors for lymph node involvement
- (2018) Sébastien Aubert et al. VIRCHOWS ARCHIV
- Precision Targeted Therapy with BLU-667 for RET -Driven Cancers
- (2018) Vivek Subbiah et al. Cancer Discovery
- Efficacy of Vandetanib in Treating Locally Advanced or Metastatic Medullary Thyroid Carcinoma According to RECIST Criteria: A Systematic Review and Meta-Analysis
- (2018) Pierpaolo Trimboli et al. Frontiers in Endocrinology
- Prognostic Significance of Circulating RET M918T Mutated Tumor DNA in Patients With Advanced Medullary Thyroid Carcinoma
- (2017) Gilbert J Cote et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma
- (2017) Song Ye et al. ONCOLOGY REPORTS
- ESR2 Gene and Medullary Thyroid Carcinoma
- (2017) Macarena Ruiz-Ferrer et al. THYROID
- MiR-375 and YAP1 expression profiling in medullary thyroid carcinoma and their correlation with clinical–pathological features and outcome
- (2017) Francesca Galuppini et al. VIRCHOWS ARCHIV
- Prognostic Impact of miR-224 and RAS Mutations in Medullary Thyroid Carcinoma
- (2017) Elisabetta Cavedon et al. International Journal of Endocrinology
- Germline ESR2 mutation predisposes to medullary thyroid carcinoma and causes up-regulation of RET expression
- (2016) Joel Smith et al. HUMAN MOLECULAR GENETICS
- Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
- (2016) Muhammad S. Beg et al. INVESTIGATIONAL NEW DRUGS
- New insights in the molecular signature of advanced medullary thyroid cancer: evidence of a bad outcome of cases with doubleRETmutations
- (2016) Cristina Romei et al. JOURNAL OF MEDICAL GENETICS
- Role of CDKN2C Copy Number in Sporadic Medullary Thyroid Carcinoma
- (2016) Elizabeth G. Grubbs et al. THYROID
- Genetic and epigenetic factors affect RET gene expression in breast cancer cell lines and influence survival in patients
- (2016) Paola Griseri et al. Oncotarget
- Genetic and epigenetic background and protein expression profiles in relation to telomerase activation in medullary thyroid carcinoma
- (2016) Na Wang et al. Oncotarget
- MicroRNA-375/SEC23A as biomarkers of the in vitro efficacy of vandetanib
- (2016) Sandra Lassalle et al. Oncotarget
- RASproto-oncogene in medullary thyroid carcinoma
- (2015) Margarida M Moura et al. ENDOCRINE-RELATED CANCER
- The PDCD4/miR-21 pathway in medullary thyroid carcinoma
- (2015) Gianmaria Pennelli et al. HUMAN PATHOLOGY
- Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
- (2015) Samuel A. Wells et al. THYROID
- Beneficial Effects of the mTOR Inhibitor Everolimus in Patients with Advanced Medullary Thyroid Carcinoma: Subgroup Results of a Phase II Trial
- (2015) T. C. Schneider et al. International Journal of Endocrinology
- Guidelines for the management of thyroid cancer
- (2014) Petros Perros et al. CLINICAL ENDOCRINOLOGY
- mTOR activation in medullary thyroid carcinoma with RAS mutation
- (2014) Joana Lyra et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Polymorphisms of cell cycle control genes influence the development of sporadic medullary thyroid carcinoma
- (2014) R B Barbieri et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- RET Mutation and Expression in Small-Cell Lung Cancer
- (2014) Snehal Dabir et al. Journal of Thoracic Oncology
- Epigenetic-related gene expression profile in medullary thyroid cancer revealed the overexpression of the histone methyltransferases EZH2 and SMYD3 in aggressive tumours
- (2014) Marialuisa Sponziello et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomas
- (2014) Michele Simbolo et al. VIRCHOWS ARCHIV
- Non-coding RNAs as direct and indirect modulators of epigenetic regulation
- (2013) Veronica J Peschansky et al. Epigenetics
- The Effect of Extent of Surgery and Number of Lymph Node Metastases on Overall Survival in Patients with Medullary Thyroid Cancer
- (2013) Nazanene H. Esfandiari et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cabozantinib in Progressive Medullary Thyroid Cancer
- (2013) Rossella Elisei et al. JOURNAL OF CLINICAL ONCOLOGY
- The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas
- (2013) T Liu et al. ONCOGENE
- Cancer Epigenetics: From Mechanism to Therapy
- (2012) Mark A. Dawson et al. CELL
- Activation of the mTOR Pathway in Primary Medullary Thyroid Carcinoma and Lymph Node Metastases
- (2012) A. Tamburrino et al. CLINICAL CANCER RESEARCH
- Low Prevalence of the Somatic M918T RET Mutation in Micro-Medullary Thyroid Cancer
- (2012) Cristina Romei et al. THYROID
- MicroRNA Profiles in Familial and Sporadic Medullary Thyroid Carcinoma: Preliminary Relationships with RET Status and Outcome
- (2012) Caterina Mian et al. THYROID
- Evidence of a Low Prevalence of RAS Mutations in a Large Medullary Thyroid Cancer Series
- (2012) Raffaele Ciampi et al. THYROID
- MicroRNA Profiling of Sporadic and Hereditary Medullary Thyroid Cancer Identifies Predictors of Nodal Metastasis, Prognosis, and Potential Therapeutic Targets
- (2011) D. Abraham et al. CLINICAL CANCER RESEARCH
- Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification
- (2011) Caterina Mian et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- High Prevalence ofRASMutations inRET-Negative Sporadic Medullary Thyroid Carcinomas
- (2011) Margarida M. Moura et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
- (2011) Samuel A. Wells et al. JOURNAL OF CLINICAL ONCOLOGY
- miR-183 inhibits TGF-β1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells
- (2010) Jipeng Li et al. BMC CANCER
- RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC)
- (2010) C. Romei et al. CLINICAL ENDOCRINOLOGY
- Correlation of RET somatic mutations with clinicopathological features in sporadic medullary thyroid carcinomas
- (2009) M M Moura et al. BRITISH JOURNAL OF CANCER
- Molecular genetics of medullary thyroid carcinoma: the quest for novel therapeutic targets
- (2009) Aniello Cerrato et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Modeling Genomic Diversity and Tumor Dependency in Malignant Melanoma
- (2008) W. M. Lin et al. CANCER RESEARCH
- Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinomas
- (2008) S. Dvorakova et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Prognostic Significance of SomaticRETOncogene Mutations in Sporadic Medullary Thyroid Cancer: A 10-Year Follow-Up Study
- (2007) Rossella Elisei et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started